Peptide Database

A tripeptide (Ala-His-Lys) copper complex that acts as a hair follicle stimulant, distinct from GHK-Cu. AHK-Cu specifically activates hair follicle stem cells and has been shown in in vitro studies to increase hair follicle size and activity by 153%, making it more hair-growth focused than GHK-Cu while sharing similar anti-aging and wound healing properties.

A natural pineal gland peptide bioregulator complex. Distinct from Epithalon (synthetic tetrapeptide) and Pinealon (synthetic tripeptide), Endoluten contains natural pineal peptide fractions that regulate melatonin production, circadian rhythms, and age-related neuroendocrine decline.

A synthetic tetrapeptide that activates telomerase, the enzyme responsible for lengthening telomeres. One of the only compounds with robust evidence for telomere extension in humans.

A D-retro-inverso peptide that selectively induces apoptosis (programmed cell death) in senescent "zombie" cells. Based on a landmark 2017 Nature Medicine paper by van Deursen et al., it is one of the most targeted senolytic compounds under research.

A naturally occurring copper-binding tripeptide that declines with age. Promotes skin rejuvenation, wound healing, hair growth, and anti-inflammatory effects. One of the most studied anti-aging peptides.

An adrenal gland-targeting peptide bioregulator. Normalizes adrenal cortex cell function and cortisol synthesis, reduces adrenal fatigue, and supports HPA axis recovery. Studied for HPA dysregulation, adrenal insufficiency, and stress-related aging.

A 21-amino acid mitochondria-derived peptide encoded in the 12S rRNA gene of the mitochondrial genome. The first discovered mitochondrial-derived peptide (MDP). Humanin protects neurons from Alzheimer-related toxicity, reduces cell death in multiple disease models, and has demonstrated significant anti-aging and longevity effects in animal studies.

The body's master antioxidant and a tripeptide (Glu-Cys-Gly) found in virtually every cell. Injectable and IV glutathione dramatically raises systemic levels for anti-aging, skin brightening, neuroprotection, liver detoxification, and chronic disease management. Oral bioavailability is poor; injectable forms bypass absorption limitations.

A synthetic tetrapeptide (Lys-Glu-Asp-Ala) from the Khavinson bioregulator series that de-heterochromatinizes age-condensed chromatin in lymphocytes, restoring youthful gene expression patterns. Hepatoprotective and immunomodulatory. One of the most mechanistically unique anti-aging peptides — it directly reactivates genes silenced by chromatin condensation with age.

A coenzyme found in all living cells, essential for cellular energy production, DNA repair, and sirtuin activation. NAD+ levels decline with age by up to 50%, contributing to metabolic dysfunction and aging. Injectable NAD+ therapy is studied for anti-aging, addiction treatment, and neurological disease.

A direct precursor to NAD+ that is more bioavailable than NAD+ itself. NMN is converted to NAD+ via the NMN/NR pathway in cells. Extensively studied in David Sinclair's lab as a longevity compound.

A synthetic octapeptide designed to mimic the N-terminal end of the SNAP-25 protein, competing with its binding site in the SNARE complex. Inhibits neuromuscular vesicle fusion at the dermal-epidermal junction, reducing expression-line depth and preventing dynamic wrinkle formation. Often called the "topical alternative to Botox."

A mitochondria-targeted tetrapeptide that localizes to the inner mitochondrial membrane, reduces oxidative stress, and restores ATP production. In Phase 2/3 clinical trials for mitochondrial myopathy, heart failure, and age-related diseases.

A thyroid-targeting tetrapeptide bioregulator from the Khavinson series. Normalizes thyroid cell function, thyroid hormone synthesis, and thyroid morphology. Studied for hypothyroidism, autoimmune thyroiditis, and thyroid aging. One of the most widely used Khavinson organ bioregulators given the high prevalence of thyroid dysfunction.

A peptide bioregulator targeting blood vessel walls from the Khavinson series. Normalizes vascular endothelial cell function, reduces oxidative damage to vessel walls, and improves microcirculation. Distinct from Vesugen (which is the synthetic tripeptide form) in being the natural extract-based vascular bioregulator complex.

A synthetic tripeptide from the Khavinson bioregulator series designed to support vascular health and blood vessel integrity.

A synthetic dipeptide from the Khavinson bioregulator series. Primarily acts as a thymus and immune regulator with demonstrated anti-aging properties.

A retina-targeting peptide bioregulator. One of the most unique organ bioregulators, targeting retinal photoreceptor cells. Studied for age-related macular degeneration (AMD), retinal dystrophy, glaucoma, and prevention of age-related vision loss.